- Home
- GH vs PLXS Comparison
GH vs PLXS Comparison
Compare GH & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- PLXS
- Stock Information
- Founded
- GH 2011
- PLXS 1979
- Country
- GH United States
- PLXS United States
- Employees
- GH N/A
- PLXS 20000
- Industry
- GH Medical Specialities
- PLXS Electrical Products
- Sector
- GH Health Care
- PLXS Technology
- Exchange
- GH Nasdaq
- PLXS Nasdaq
- Market Cap
- GH 6.1B
- PLXS 3.8B
- IPO Year
- GH 2018
- PLXS 1986
- Fundamental
- Price
- GH $47.17
- PLXS $140.34
- Analyst Decision
- GH Strong Buy
- PLXS Buy
- Analyst Count
- GH 15
- PLXS 4
- Target Price
- GH $42.57
- PLXS $164.00
- AVG Volume (30 Days)
- GH 2.6M
- PLXS 185.7K
- Earning Date
- GH 02-20-2025
- PLXS 01-22-2025
- Dividend Yield
- GH N/A
- PLXS N/A
- EPS Growth
- GH N/A
- PLXS N/A
- EPS
- GH N/A
- PLXS 4.31
- Revenue
- GH $692,256,000.00
- PLXS $3,954,342,000.00
- Revenue This Year
- GH $32.40
- PLXS $7.93
- Revenue Next Year
- GH $16.92
- PLXS $11.60
- P/E Ratio
- GH N/A
- PLXS $32.19
- Revenue Growth
- GH 29.20
- PLXS N/A
- 52 Week Low
- GH $15.81
- PLXS $90.18
- 52 Week High
- GH $50.89
- PLXS $172.89
- Technical
- Relative Strength Index (RSI)
- GH 66.04
- PLXS 30.25
- Support Level
- GH $44.10
- PLXS $136.21
- Resistance Level
- GH $50.89
- PLXS $146.97
- Average True Range (ATR)
- GH 2.75
- PLXS 4.34
- MACD
- GH 0.21
- PLXS -2.31
- Stochastic Oscillator
- GH 74.24
- PLXS 11.26
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About PLXS Plexus Corp.
Plexus Corp is a U.S based Electronic Manufacturing Services company that provides a range of services, from conceptualization and design to fulfilling orders and providing sustaining solutions, such as replenishment and refurbishment. The company's segments comprise AMER, APAC,ge and EMEA.